APO Research
Talk to an analyst

APO RESEARCH · REPORT

IVD CDMO

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global IVD CDMO Market Outlook and Growth Opportunities 2026

16 April 2026Not stated

Choose your research edition.

Industry ResearchIVD CDMO Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal IVD CDMO Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal IVD CDMO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal IVD CDMO Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal IVD CDMO Market Analysis and Forecast 2026-2032248 pages · $4,950 USD

Market perspective

The global IVD CDMO market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for IVD CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for IVD CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for IVD CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the IVD CDMO market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the IVD CDMO market include Hitachi, Canon, TE Connectivity, JEOL, HU Group, DCN DX, Stevanato, Argonaut and Erreka, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global IVD CDMO market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of IVD CDMO and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents IVD CDMO revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global IVD CDMO market.

IVD CDMO Segment by Company

Hitachi

Canon

TE Connectivity

JEOL

HU Group

DCN DX

Stevanato

Argonaut

Erreka

GBC

Phillips Medisize

AIVD Biotech

Kaishi Biological Technology

Keysmile Biological Technology

Nabai Medical Technology

Hochuen Medical

IVD CDMO Segment by Type

Molecular Diagnosis

Immunodiagnosis

Biochemical Diagnosis

Other

IVD CDMO Segment by Application

Instruments

Consumables

IVD CDMO Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global IVD CDMO status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the IVD CDMO key companies, revenue, market share, and recent developments.

3. To split the IVD CDMO breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions IVD CDMO market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify IVD CDMO significant trends, drivers, influence factors in global and regions.

6. To analyze IVD CDMO competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IVD CDMO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of IVD CDMO and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IVD CDMO.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global IVD CDMO industry.

Chapter 3: Detailed analysis of IVD CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of IVD CDMO in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of IVD CDMO in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. IVD CDMO Industry Trends Table 2. IVD CDMO Industry Drivers Table 3. IVD CDMO Industry Opportunities and Challenges Table 4. IVD CDMO Industry Restraints Table 5. Global IVD CDMO Revenue by Company (US$ Million) & (2021-2026) Table 6. Global IVD CDMO Revenue Share by Company (2021-2026) Table 7. Global IVD CDMO Company Ranking, (2024-2026) & (US$ Million) Table 8. Global IVD CDMO Key Company Manufacturing Base & Headquarters Table 9. Global IVD CDMO Company, Product Type & Application Table 10. Global IVD CDMO Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global IVD CDMO by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Molecular Diagnosis Table 15. Significant Companies of Immunodiagnosis Table 16. Significant Companies of Biochemical Diagnosis Table 17. Significant Companies of Other Table 18. Global IVD CDMO Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global IVD CDMO Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global IVD CDMO Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global IVD CDMO Sales Value Share by Type (2021-2026) Table 22. Global IVD CDMO Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Instruments Table 24. Significant Companies of Consumables Table 25. Global IVD CDMO Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global IVD CDMO Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global IVD CDMO Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global IVD CDMO Sales Value Share by Application (2021-2026) Table 29. Global IVD CDMO Sales Value Share by Application (2027-2032) Table 30. Global IVD CDMO Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global IVD CDMO Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global IVD CDMO Sales Value Share by Region (2021-2026) Table 33. Global IVD CDMO Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global IVD CDMO Sales Value Share by Region (2027-2032) Table 35. Global IVD CDMO Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global IVD CDMO Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global IVD CDMO Sales Value Market Share by Country (2021-2026) Table 38. Global IVD CDMO Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global IVD CDMO Sales Value Market Share by Country (2027-2032) Table 40. Hitachi Company Information Table 41. Hitachi Business Overview Table 42. Hitachi IVD CDMO Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Hitachi IVD CDMO Product Portfolio Table 44. Hitachi Recent Development Table 45. Canon Company Information Table 46. Canon Business Overview Table 47. Canon IVD CDMO Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Canon IVD CDMO Product Portfolio Table 49. Canon Recent Development Table 50. TE Connectivity Company Information Table 51. TE Connectivity Business Overview Table 52. TE Connectivity IVD CDMO Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. TE Connectivity IVD CDMO Product Portfolio Table 54. TE Connectivity Recent Development Table 55. JEOL Company Information Table 56. JEOL Business Overview Table 57. JEOL IVD CDMO Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. JEOL IVD CDMO Product Portfolio Table 59. JEOL Recent Development Table 60. HU Group Company Information Table 61. HU Group Business Overview Table 62. HU Group IVD CDMO Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. HU Group IVD CDMO Product Portfolio Table 64. HU Group Recent Development Table 65. DCN DX Company Information Table 66. DCN DX Business Overview Table 67. DCN DX IVD CDMO Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. DCN DX IVD CDMO Product Portfolio Table 69. DCN DX Recent Development Table 70. Stevanato Company Information Table 71. Stevanato Business Overview Table 72. Stevanato IVD CDMO Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Stevanato IVD CDMO Product Portfolio Table 74. Stevanato Recent Development Table 75. Argonaut Company Information Table 76. Argonaut Business Overview Table 77. Argonaut IVD CDMO Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Argonaut IVD CDMO Product Portfolio Table 79. Argonaut Recent Development Table 80. Erreka Company Information Table 81. Erreka Business Overview Table 82. Erreka IVD CDMO Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Erreka IVD CDMO Product Portfolio Table 84. Erreka Recent Development Table 85. GBC Company Information Table 86. GBC Business Overview Table 87. GBC IVD CDMO Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. GBC IVD CDMO Product Portfolio Table 89. GBC Recent Development Table 90. Phillips Medisize Company Information Table 91. Phillips Medisize Business Overview Table 92. Phillips Medisize IVD CDMO Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Phillips Medisize IVD CDMO Product Portfolio Table 94. Phillips Medisize Recent Development Table 95. AIVD Biotech Company Information Table 96. AIVD Biotech Business Overview Table 97. AIVD Biotech IVD CDMO Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. AIVD Biotech IVD CDMO Product Portfolio Table 99. AIVD Biotech Recent Development Table 100. Kaishi Biological Technology Company Information Table 101. Kaishi Biological Technology Business Overview Table 102. Kaishi Biological Technology IVD CDMO Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Kaishi Biological Technology IVD CDMO Product Portfolio Table 104. Kaishi Biological Technology Recent Development Table 105. Keysmile Biological Technology Company Information Table 106. Keysmile Biological Technology Business Overview Table 107. Keysmile Biological Technology IVD CDMO Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Keysmile Biological Technology IVD CDMO Product Portfolio Table 109. Keysmile Biological Technology Recent Development Table 110. Nabai Medical Technology Company Information Table 111. Nabai Medical Technology Business Overview Table 112. Nabai Medical Technology IVD CDMO Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Nabai Medical Technology IVD CDMO Product Portfolio Table 114. Nabai Medical Technology Recent Development Table 115. Hochuen Medical Company Information Table 116. Hochuen Medical Business Overview Table 117. Hochuen Medical IVD CDMO Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Hochuen Medical IVD CDMO Product Portfolio Table 119. Hochuen Medical Recent Development Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. IVD CDMO Product Image Figure 2. Global IVD CDMO Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global IVD CDMO Market Size (2021-2032) & (US$ Million) Figure 4. Global IVD CDMO Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Molecular Diagnosis Image Figure 8. Immunodiagnosis Image Figure 9. Biochemical Diagnosis Image Figure 10. Other Image Figure 11. Global IVD CDMO Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global IVD CDMO Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global IVD CDMO Sales Value Share by Type (2021-2032) Figure 14. Instruments Image Figure 15. Consumables Image Figure 16. Global IVD CDMO Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global IVD CDMO Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global IVD CDMO Sales Value Share by Application (2021-2032) Figure 19. Global IVD CDMO Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global IVD CDMO Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America IVD CDMO Sales Value (2021-2032) & (US$ Million) Figure 22. North America IVD CDMO Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe IVD CDMO Sales Value (2021-2032) & (US$ Million) Figure 24. Europe IVD CDMO Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific IVD CDMO Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific IVD CDMO Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America IVD CDMO Sales Value (2021-2032) & (US$ Million) Figure 28. South America IVD CDMO Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa IVD CDMO Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa IVD CDMO Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA IVD CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA IVD CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA IVD CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada IVD CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada IVD CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada IVD CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico IVD CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico IVD CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico IVD CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany IVD CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany IVD CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany IVD CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France IVD CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France IVD CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France IVD CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. IVD CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. IVD CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. IVD CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy IVD CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy IVD CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy IVD CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain IVD CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain IVD CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain IVD CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia IVD CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia IVD CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia IVD CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands IVD CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands IVD CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands IVD CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries IVD CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries IVD CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries IVD CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China IVD CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China IVD CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China IVD CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan IVD CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan IVD CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan IVD CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea IVD CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea IVD CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea IVD CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India IVD CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India IVD CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India IVD CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia IVD CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia IVD CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia IVD CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia IVD CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia IVD CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia IVD CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil IVD CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil IVD CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil IVD CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina IVD CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina IVD CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina IVD CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile IVD CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile IVD CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile IVD CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia IVD CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia IVD CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia IVD CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru IVD CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru IVD CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru IVD CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia IVD CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia IVD CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia IVD CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel IVD CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel IVD CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel IVD CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE IVD CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE IVD CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE IVD CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey IVD CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey IVD CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey IVD CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran IVD CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran IVD CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran IVD CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt IVD CDMO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt IVD CDMO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt IVD CDMO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Molecular Diagnosis
  • Immunodiagnosis
  • Biochemical Diagnosis
  • Other
Applications
  • Instruments
  • Consumables
Companies covered
  • Hitachi
  • Canon
  • TE Connectivity
  • JEOL
  • HU Group
  • DCN DX
  • Stevanato
  • Argonaut
  • Erreka
  • GBC
  • Phillips Medisize
  • AIVD Biotech
  • Kaishi Biological Technology
  • Keysmile Biological Technology
  • Nabai Medical Technology
  • Hochuen Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global IVD CDMO Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global IVD CDMO Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 IVD CDMO Market Dynamics
  1. 2.1 IVD CDMO Industry Trends
  2. 2.2 IVD CDMO Industry Drivers
  3. 2.3 IVD CDMO Industry Opportunities and Challenges
  4. 2.4 IVD CDMO Industry Restraints
3 IVD CDMO Market by Company
  1. 3.1 Global IVD CDMO Company Revenue Ranking in 2025
  2. 3.2 Global IVD CDMO Revenue by Company (2021-2026)
  3. 3.3 Global IVD CDMO Company Ranking (2024-2026)
  4. 3.4 Global IVD CDMO Company Manufacturing Base and Headquarters
  5. 3.5 Global IVD CDMO Company Product Type and Application
  6. 3.6 Global IVD CDMO Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global IVD CDMO Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 IVD CDMO Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 IVD CDMO Market by Type
  1. 4.1 IVD CDMO Type Introduction
  2. 4.1.1 Molecular Diagnosis
  3. 4.1.2 Immunodiagnosis
  4. 4.1.3 Biochemical Diagnosis
  5. 4.1.4 Other
  6. 4.2 Global IVD CDMO Sales Value by Type
  7. 4.2.1 Global IVD CDMO Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global IVD CDMO Sales Value by Type (2021-2032)
  9. 4.2.3 Global IVD CDMO Sales Value Share by Type (2021-2032)
5 IVD CDMO Market by Application
  1. 5.1 IVD CDMO Application Introduction
  2. 5.1.1 Instruments
  3. 5.1.2 Consumables
  4. 5.2 Global IVD CDMO Sales Value by Application
  5. 5.2.1 Global IVD CDMO Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global IVD CDMO Sales Value by Application (2021-2032)
  7. 5.2.3 Global IVD CDMO Sales Value Share by Application (2021-2032)
6 IVD CDMO Regional Value Analysis
  1. 6.1 Global IVD CDMO Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global IVD CDMO Sales Value by Region (2021-2032)
  3. 6.2.1 Global IVD CDMO Sales Value by Region: 2021-2026
  4. 6.2.2 Global IVD CDMO Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America IVD CDMO Sales Value (2021-2032)
  7. 6.3.2 North America IVD CDMO Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe IVD CDMO Sales Value (2021-2032)
  10. 6.4.2 Europe IVD CDMO Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific IVD CDMO Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific IVD CDMO Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America IVD CDMO Sales Value (2021-2032)
  16. 6.6.2 South America IVD CDMO Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa IVD CDMO Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa IVD CDMO Sales Value Share by Country, 2025 VS 2032
7 IVD CDMO Country-level Value Analysis
  1. 7.1 Global IVD CDMO Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global IVD CDMO Sales Value by Country (2021-2032)
  3. 7.2.1 Global IVD CDMO Sales Value by Country (2021-2026)
  4. 7.2.2 Global IVD CDMO Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA IVD CDMO Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA IVD CDMO Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA IVD CDMO Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada IVD CDMO Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada IVD CDMO Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada IVD CDMO Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico IVD CDMO Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico IVD CDMO Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico IVD CDMO Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany IVD CDMO Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany IVD CDMO Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany IVD CDMO Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France IVD CDMO Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France IVD CDMO Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France IVD CDMO Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. IVD CDMO Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. IVD CDMO Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. IVD CDMO Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy IVD CDMO Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy IVD CDMO Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy IVD CDMO Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain IVD CDMO Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain IVD CDMO Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain IVD CDMO Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia IVD CDMO Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia IVD CDMO Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia IVD CDMO Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands IVD CDMO Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands IVD CDMO Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands IVD CDMO Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries IVD CDMO Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries IVD CDMO Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries IVD CDMO Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China IVD CDMO Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China IVD CDMO Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China IVD CDMO Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan IVD CDMO Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan IVD CDMO Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan IVD CDMO Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea IVD CDMO Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea IVD CDMO Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea IVD CDMO Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India IVD CDMO Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India IVD CDMO Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India IVD CDMO Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia IVD CDMO Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia IVD CDMO Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia IVD CDMO Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia IVD CDMO Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia IVD CDMO Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia IVD CDMO Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil IVD CDMO Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil IVD CDMO Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil IVD CDMO Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina IVD CDMO Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina IVD CDMO Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina IVD CDMO Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile IVD CDMO Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile IVD CDMO Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile IVD CDMO Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia IVD CDMO Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia IVD CDMO Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia IVD CDMO Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru IVD CDMO Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru IVD CDMO Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru IVD CDMO Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia IVD CDMO Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia IVD CDMO Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia IVD CDMO Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel IVD CDMO Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel IVD CDMO Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel IVD CDMO Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE IVD CDMO Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE IVD CDMO Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE IVD CDMO Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey IVD CDMO Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey IVD CDMO Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey IVD CDMO Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran IVD CDMO Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran IVD CDMO Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran IVD CDMO Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt IVD CDMO Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt IVD CDMO Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt IVD CDMO Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Hitachi
  2. 8.1.1 Hitachi Company Information
  3. 8.1.2 Hitachi Business Overview
  4. 8.1.3 Hitachi IVD CDMO Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Hitachi IVD CDMO Product Portfolio
  6. 8.1.5 Hitachi Recent Developments
  7. 8.2 Canon
  8. 8.2.1 Canon Company Information
  9. 8.2.2 Canon Business Overview
  10. 8.2.3 Canon IVD CDMO Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Canon IVD CDMO Product Portfolio
  12. 8.2.5 Canon Recent Developments
  13. 8.3 TE Connectivity
  14. 8.3.1 TE Connectivity Company Information
  15. 8.3.2 TE Connectivity Business Overview
  16. 8.3.3 TE Connectivity IVD CDMO Revenue and Gross Margin (2021-2026)
  17. 8.3.4 TE Connectivity IVD CDMO Product Portfolio
  18. 8.3.5 TE Connectivity Recent Developments
  19. 8.4 JEOL
  20. 8.4.1 JEOL Company Information
  21. 8.4.2 JEOL Business Overview
  22. 8.4.3 JEOL IVD CDMO Revenue and Gross Margin (2021-2026)
  23. 8.4.4 JEOL IVD CDMO Product Portfolio
  24. 8.4.5 JEOL Recent Developments
  25. 8.5 HU Group
  26. 8.5.1 HU Group Company Information
  27. 8.5.2 HU Group Business Overview
  28. 8.5.3 HU Group IVD CDMO Revenue and Gross Margin (2021-2026)
  29. 8.5.4 HU Group IVD CDMO Product Portfolio
  30. 8.5.5 HU Group Recent Developments
  31. 8.6 DCN DX
  32. 8.6.1 DCN DX Company Information
  33. 8.6.2 DCN DX Business Overview
  34. 8.6.3 DCN DX IVD CDMO Revenue and Gross Margin (2021-2026)
  35. 8.6.4 DCN DX IVD CDMO Product Portfolio
  36. 8.6.5 DCN DX Recent Developments
  37. 8.7 Stevanato
  38. 8.7.1 Stevanato Company Information
  39. 8.7.2 Stevanato Business Overview
  40. 8.7.3 Stevanato IVD CDMO Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Stevanato IVD CDMO Product Portfolio
  42. 8.7.5 Stevanato Recent Developments
  43. 8.8 Argonaut
  44. 8.8.1 Argonaut Company Information
  45. 8.8.2 Argonaut Business Overview
  46. 8.8.3 Argonaut IVD CDMO Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Argonaut IVD CDMO Product Portfolio
  48. 8.8.5 Argonaut Recent Developments
  49. 8.9 Erreka
  50. 8.9.1 Erreka Company Information
  51. 8.9.2 Erreka Business Overview
  52. 8.9.3 Erreka IVD CDMO Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Erreka IVD CDMO Product Portfolio
  54. 8.9.5 Erreka Recent Developments
  55. 8.10 GBC
  56. 8.10.1 GBC Company Information
  57. 8.10.2 GBC Business Overview
  58. 8.10.3 GBC IVD CDMO Revenue and Gross Margin (2021-2026)
  59. 8.10.4 GBC IVD CDMO Product Portfolio
  60. 8.10.5 GBC Recent Developments
  61. 8.11 Phillips Medisize
  62. 8.11.1 Phillips Medisize Company Information
  63. 8.11.2 Phillips Medisize Business Overview
  64. 8.11.3 Phillips Medisize IVD CDMO Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Phillips Medisize IVD CDMO Product Portfolio
  66. 8.11.5 Phillips Medisize Recent Developments
  67. 8.12 AIVD Biotech
  68. 8.12.1 AIVD Biotech Company Information
  69. 8.12.2 AIVD Biotech Business Overview
  70. 8.12.3 AIVD Biotech IVD CDMO Revenue and Gross Margin (2021-2026)
  71. 8.12.4 AIVD Biotech IVD CDMO Product Portfolio
  72. 8.12.5 AIVD Biotech Recent Developments
  73. 8.13 Kaishi Biological Technology
  74. 8.13.1 Kaishi Biological Technology Company Information
  75. 8.13.2 Kaishi Biological Technology Business Overview
  76. 8.13.3 Kaishi Biological Technology IVD CDMO Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Kaishi Biological Technology IVD CDMO Product Portfolio
  78. 8.13.5 Kaishi Biological Technology Recent Developments
  79. 8.14 Keysmile Biological Technology
  80. 8.14.1 Keysmile Biological Technology Company Information
  81. 8.14.2 Keysmile Biological Technology Business Overview
  82. 8.14.3 Keysmile Biological Technology IVD CDMO Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Keysmile Biological Technology IVD CDMO Product Portfolio
  84. 8.14.5 Keysmile Biological Technology Recent Developments
  85. 8.15 Nabai Medical Technology
  86. 8.15.1 Nabai Medical Technology Company Information
  87. 8.15.2 Nabai Medical Technology Business Overview
  88. 8.15.3 Nabai Medical Technology IVD CDMO Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Nabai Medical Technology IVD CDMO Product Portfolio
  90. 8.15.5 Nabai Medical Technology Recent Developments
  91. 8.16 Hochuen Medical
  92. 8.16.1 Hochuen Medical Company Information
  93. 8.16.2 Hochuen Medical Business Overview
  94. 8.16.3 Hochuen Medical IVD CDMO Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Hochuen Medical IVD CDMO Product Portfolio
  96. 8.16.5 Hochuen Medical Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst